Bioatla added to membership of u.s. small-cap russell 2000® index

San diego, june 26, 2023 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today announced that the company has been added as a member of the u.s. small-cap russell 2000® index, effective after the u.s. markets open on june 26, 2023, as part of the 2023 russell indexes reconstitution in the broad-market russell 3000® index. the stock also was automatically added to the appropriate growth and value indexes.
BCAB Ratings Summary
BCAB Quant Ranking